Literature DB >> 33512588

Risk factors for deep surgical site infection following posterior instrumented fusion for degenerative diseases in the thoracic and/or lumbar spine: a multicenter, observational cohort study of 2913 consecutive cases.

Satoshi Ogihara1, Takashi Yamazaki2, Michio Shiibashi3, Hirotaka Chikuda4, Toru Maruyama5, Kota Miyoshi6, Hirohiko Inanami7, Yasushi Oshima8, Seiichi Azuma9, Naohiro Kawamura10, Kiyofumi Yamakawa11, Nobuhiro Hara2, Jiro Morii12, Rentaro Okazaki9, Yujiro Takeshita6, Sakae Tanaka8, Kazuo Saita13.   

Abstract

PURPOSE: Surgical site infection (SSI) is one of the most devastating complications following spinal instrumented fusion surgeries because it may lead to a significant increase in morbidity, mortality, and poor clinical outcomes. Identifying the risk factors for SSI can help in developing strategies to reduce its occurrence. However, data on the risk factors for SSI in degenerative diseases are limited. This study aimed to identify risk factors for deep SSI following posterior instrumented fusion for degenerative diseases in the thoracic and/or lumbar spine in adult patients.
METHODS: This was a multicenter, observational cohort study conducted at 10 study hospitals between July 2010 and June 2015. The subjects were consecutive adult patients who underwent posterior instrumented fusion surgery for degenerative diseases in the thoracic and/or lumbar spine and developed SSI. Detailed patient-specific and procedure-specific potential risk variables were prospectively recorded using a standardized data collection chart and retrospectively reviewed.
RESULTS: Of the 2913 enrolled patients, 35 developed postoperative deep SSI (1.2%). Multivariable regression analysis identified three independent risk factors: male sex (P = 0.002) and American Society of Anesthesiologists (ASA) score of ≥ 3 (P = 0.003) as patient-specific risk factors, and operation including the thoracic spine (P = 0.018) as a procedure-specific risk factor.
CONCLUSION: Thoracic spinal surgery, an ASA score of ≥ 3, and male sex were risk factors for deep SSI after routine thoracolumbar instrumented fusion surgeries for degenerative diseases. Awareness of these risk factors can enable surgeons to develop a more appropriate management plan and provide better patient counseling.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Lumbar; Risk factors; Spine; Surgical site infection; Thoracic

Year:  2021        PMID: 33512588     DOI: 10.1007/s00586-020-06609-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  31 in total

1.  Risk of infection following posterior instrumented lumbar fusion for degenerative spine disease in 817 consecutive cases.

Authors:  Kaisorn L Chaichana; Mohamad Bydon; David R Santiago-Dieppa; Lee Hwang; Gregory McLoughlin; Daniel M Sciubba; Jean-Paul Wolinsky; Ali Bydon; Ziya L Gokaslan; Timothy Witham
Journal:  J Neurosurg Spine       Date:  2013-11-08

2.  Risk factors for surgical site infections following spinal fusion procedures: a case-control study.

Authors:  Shilpa B Rao; Gustavo Vasquez; James Harrop; Mitchell Maltenfort; Natalie Stein; George Kaliyadan; Frank Klibert; Richard Epstein; Ashwini Sharan; Alexander Vaccaro; Phyllis Flomenberg
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

3.  Risk factors for deep surgical site infections after spinal fusion.

Authors:  J J P Schimmel; P P Horsting; M de Kleuver; G Wonders; J van Limbeek
Journal:  Eur Spine J       Date:  2010-05-06       Impact factor: 3.134

4.  Surgical site infection in spinal surgery: description of surgical and patient-based risk factors for postoperative infection using administrative claims data.

Authors:  Amir Abdul-Jabbar; Steven Takemoto; Michael H Weber; Serena S Hu; Praveen V Mummaneni; Vedat Deviren; Christopher P Ames; Dean Chou; Philip R Weinstein; Shane Burch; Sigurd H Berven
Journal:  Spine (Phila Pa 1976)       Date:  2012-07-01       Impact factor: 3.468

5.  A prediction model of surgical site infection after instrumented thoracolumbar spine surgery in adults.

Authors:  Daniël M C Janssen; Sander M J van Kuijk; Boudewijn d'Aumerie; Paul Willems
Journal:  Eur Spine J       Date:  2019-01-07       Impact factor: 3.134

6.  Incidence, Prevalence, and Analysis of Risk Factors for Surgical Site Infection After Lumbar Fusion Surgery: ≥2-Year Follow-Up Retrospective Study.

Authors:  Zhonghai Li; Peng Liu; Chunli Zhang; Gang Xu; Yu Zhang; Yvang Chang; Mozhen Liu; Shuxun Hou
Journal:  World Neurosurg       Date:  2019-08-05       Impact factor: 2.104

7.  What are the risk factors for surgical site infection after spinal fusion? A meta-analysis.

Authors:  Sebastien Pesenti; Tejbir Pannu; Jessica Andres-Bergos; Renaud Lafage; Justin S Smith; Steve Glassman; Marinus de Kleuver; Ferran Pellise; Frank Schwab; Virginie Lafage
Journal:  Eur Spine J       Date:  2018-08-20       Impact factor: 3.134

8.  Preoperative Predictors of Spinal Infection within the National Surgical Quality Inpatient Database.

Authors:  Bryan Lieber; ByoungJun Han; Russell G Strom; Jeffrey Mullin; Anthony K Frempong-Boadu; Nitin Agarwal; Noojan Kazemi; Monir Tabbosha
Journal:  World Neurosurg       Date:  2015-12-31       Impact factor: 2.104

9.  Infection risk for primary and revision instrumented lumbar spine fusion in the Medicare population.

Authors:  Steven M Kurtz; Edmund Lau; Kevin L Ong; Leah Carreon; Heather Watson; Todd Albert; Steven Glassman
Journal:  J Neurosurg Spine       Date:  2012-08-24

10.  Risk factors for surgical site infection after instrumented fixation in spine trauma.

Authors:  Kevin Cooper; Chad A Glenn; Michael Martin; Julie Stoner; Ji Li; Timothy Puckett
Journal:  J Clin Neurosci       Date:  2015-10-21       Impact factor: 1.961

View more
  1 in total

Review 1.  Prophylactic Topical Antibiotics in Fracture Repair and Spinal Fusion.

Authors:  Eric K Kim; Claire A Donnelley; Madeline Tiee; Heather J Roberts; Ericka Von Kaeppler; David Shearer; Saam Morshed
Journal:  Adv Orthop       Date:  2021-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.